Legal Press releases

2021-06-09 Legal Press releases

Report from Annual General Meeting in Intervacc

Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 9 June 2021, at which the following resolutions were made.

Due to the continued spread of the coronavirus and the authorities’ ... Read more

2021-05-28 Legal Press releases

Intervacc and the Karolinska Institutet sign a multi-year contract for the development of innovative animal health vaccines

Stockholm May 28, 2021 - Intervacc AB (publ) and the Karolinska Institute, KI, announce today that they have extended the contract for the development of a new generation of animal health vaccines using ... Read more

2021-05-21 Legal Press releases

Interim report January – March 2021

The period in summary

First quarter January 1 – March 31, 2021

The regulatory process for the Company’s Marketing Authorization Application (MAA) for Strangvac in Europe has proceeded according to plan. On January ... Read more

2021-05-10 Legal Press releases

Notice of annual general meeting in Intervacc AB (publ)

The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Wednesday 9 June 2021.
Due to the continued spread of the ... Read more

2021-04-12 Legal Press releases

Intervacc AB and Dechra Pharmaceuticals PLC enter into an Agreement to Commercialize Strangvac in Europe

Stockholm, April 12, 2021 - Intervacc AB (“Intervacc”) announced today that they have entered into an exclusive distribution agreement with Dechra Pharmaceuticals PLC, (“Dechra”) to commercialize Intervacc’s leading ... Read more

2021-03-31 Legal Press releases

Intervacc publishes the 2020 Annual Report

Stockholm, March 31, 2021 - Intervacc AB (publ) announces that the company's 2020 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is ... Read more

« Previous 1 … 18 19 20 21 22 … 25 Next »

Legal Press releases

Report from Annual General Meeting in Intervacc

Intervacc and the Karolinska Institutet sign a multi-year contract for the development of innovative animal health vaccines

Interim report January – March 2021

The period in summary

First quarter January 1 – March 31, 2021

Notice of annual general meeting in Intervacc AB (publ)

Intervacc AB and Dechra Pharmaceuticals PLC enter into an Agreement to Commercialize Strangvac in Europe

Intervacc publishes the 2020 Annual Report

Archives

Document